Replies to post #6554 on Cel Sci Corporation (CVM)

[ducruacuteo11]

Thanks, drkazmd65! I stumbled across this board by accident but there is some great posts here, better than the yahoo board. :-). The phase 2 results were pretty good with two patients had tumors completely disappeared, at least that was what got reported. My take is that they have burnt through over $200M the past 30 years and the latest batch of investors put out $6M plus warrants at $.73 so I am alright with my small investment amount. These investors must have seen or heard something, right? But, I remembered in 2010, some of the investors put in millions at $1.45 so I wonder how they feel now. Just a bit frustrating with the lack of info. or news from the company.

[peterose]

I beg to differ with you on one point. There are plenty of biotech companies who report interim data during phase one and phase two testing.
For example CytRx (CYTR) today announced positive interim phase 2 results. Stock shot up 17%.
Why CVM doesn't report mid-term CRADA results or Ergomed makes me wonder.

[kurious]

Or for that matter am not aware of any companies that have released results from Phase I or Phase II testing during those phases of testing either.
and whether the Multikine Vs. HPV warts Phase I shows any promising results.
What?

Just as one example.. The company also announced topline data from its ongoing phase 2 trial with BIND-014 in metastatic castration resistant prostate cancer (mCRPC).